Provided by Tiger Trade Technology Pte. Ltd.

Biote Corp.

0.8147
-0.0301-3.56%
Post-market: 0.8105-0.0042-0.52%19:30 EST
Volume:37.78K
Turnover:31.00K
Market Cap:29.23M
PE:-12.39
High:0.8500
Open:0.8200
Low:0.8100
Close:0.8448
52wk High:2.90
52wk Low:0.8100
Shares:35.88M
Float Shares:29.25M
Volume Ratio:0.55
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0658
EPS(LYR):0.7400
ROE:--
ROA:8.66%
PB:-0.45
PE(LYR):1.10

Loading ...

Company Profile

Company Name:
Biote Corp.
Exchange:
NASDAQ
Establishment Date:
2012
Employees:
223
Office Location:
1875 W. Walnut Hill Ln #100,Irving,Texas,United States
Zip Code:
75038
Fax:
- -
Introduction:
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Directors

Name
Position
Marc Beer
Executive Chairman and Director
Robert Peterson
Chief Financial Officer and Chief Business Officer and Interim Chief Executive Officer and Director
Andrew R. Heyer
Independent Director
Dana Jacoby
Independent Director
Debra L. Morris
Independent Director
Richard R. Barrera
Independent Director
S. Mark Cone
Independent Director
Bret Christensen
Director

Shareholders

Name
Position
Robert Peterson
Chief Financial Officer and Chief Business Officer and Interim Chief Executive Officer and Director
Marc Beer
Executive Chairman and Director